Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 
FDA: Painkiller Ads Misleading
January 14, 2005

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

Pfizer Inc. ads for the painkillers Celebrex and Bextra mislead consumers and fail to properly disclose the drugs' side-effects, the U.S. Food and Drug Administration (FDA) told the pharmaceutical company.

Reuters reported Jan. 12 that the FDA cited five separate print and TV ads for making "unsubstantiated effectiveness claims."

However, the FDA said the letter sent to Pfizer on Jan. 10 was not a warning, but rather a statement of a potential problem. A Pfizer spokesperson said the company is in discussions with the agency on the matter and has agreed not to run more ads for Celebrex. She also said there is little consumer advertising of Bextra.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)
Enter this word
(help):		 Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.